Emerging biomarkers in autism spectrum disorder: a systematic review.

Frye, Richard E; Vassall, Sarah; Kaur, Gurjot; Lewis, Christina; Karim, Mohammand; Rossignol, Daniel

Frye, Richard E; Vassall, Sarah; Kaur, Gurjot; Lewis, Christina; Karim, Mohammand; Rossignol, Daniel.

Afiliação

Frye RE; Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, USA.
Vassall S; Deparment of Child Health, University of Arizona College of Medicine, Phoenix, AZ, USA.
Kaur G; Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, USA.
Lewis C; Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, USA.
Karim M; Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, USA.
Rossignol D; Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, USA.

Ann Transl Med ; 7(23): 792, 2019 Dec.

Article em En | MEDLINE | ID: mdl-32042808

Palavras-chave

Autism spectrum disorder (ASD); biomarkers; epigenetic; eye movement; folate; genetic; methylation; mitochondria; neuroimmune; neurophysiology; redox

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Idioma: En Revista: Ann Transl Med Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google